Related Experiment Video
Updated: Apr 3, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Serum Calcification Propensity Is a Strong and Independent Determinant of Cardiac and All-Cause Mortality in Kidney
D O Dahle1,2, A Åsberg1,3,4, A Hartmann1,2
1Department of Transplant Medicine, Oslo University Hospital, Oslo, Norway.
Insights
Calcification propensity, measured by T50, is linked to higher mortality in kidney transplant recipients. This blood test may offer new insights into cardiovascular risks post-transplant.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Vascular calcification is a significant risk factor for cardiovascular disease and mortality in kidney transplant recipients.
- A novel blood test, measuring calcification propensity via calciprotein particle transformation time (T50), offers a new metric for assessing this risk.
Purpose of the Study:
- To investigate the association between calcification propensity (T50) and mortality in kidney transplant recipients.
- To explore the relationship between T50 and aortic pulse wave velocity (APWV) in this patient cohort.
Main Methods:
- T50 was measured in 1435 kidney transplant recipients across two eras (2000-2003 and 2009-2012).
- APWV was assessed in 589 patients from the second era at baseline and 1-year follow-up.
- Cox regression models were used to analyze the association between T50 and mortality over a median follow-up of 5.1 years.
Main Results:
- Accelerated T50 was associated with factors including diabetes, deceased donor, first transplant, rejection, and higher serum phosphate.
- T50 was not significantly associated with the progression of APWV.
- Accelerated T50 was independently associated with increased all-cause mortality (HR 1.60) and cardiac mortality (HR 3.60).
Conclusions:
- Calcification propensity, as measured by T50, is a strong independent predictor of both all-cause and cardiac mortality in kidney transplant recipients.
- The findings suggest a potential cardiac pathway independent of APWV, highlighting T50 as a critical biomarker.
- Further randomized trials are needed to determine if therapeutic interventions targeting T50 can improve patient outcomes.
Abstract:
Calcification of the vasculature is associated with cardiovascular disease and death in kidney transplant recipients. A novel functional blood test measures calcification propensity by quantifying the transformation time (T50 ) from primary to secondary calciprotein particles. Accelerated T50 indicates a diminished ability of serum to resist calcification. We measured T50 in 1435 patients 10 weeks after kidney transplantation during 2000-2003 (first era) and 2009-2012 (second era). Aortic pulse wave velocity (APWV) was measured at week 10 and after 1 year in 589 patients from the second era. Accelerated T50 was associated with diabetes, deceased donor, first transplant, rejection, stronger immunosuppression, first era, higher serum phosphate and lower albumin. T50 was not associated with progression of APWV. During a median follow-up of 5.1 years, 283 patients died, 70 from myocardial infarction, cardiac failure or sudden death. In Cox regression models, accelerated T50 was strongly and independently associated with both all-cause and cardiac mortality, low versus high T50 quartile: hazard ratio 1.60 (95% confidence interval [CI] 1.00-2.57), ptrend = 0.03, and 3.60 (95% CI 1.10-11.83), ptrend = 0.02, respectively. In conclusion, calcification propensity (T50 ) was strongly associated with all-cause and cardiac mortality of kidney transplant recipients, potentially via a cardiac nonAPWV-related pathway. Whether therapeutic improvement of T50 improves outcome awaits clarification in a randomized trial.
Related Concept Videos
Kidney Transplant I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease II: Clinical Manifestations
Serum Studies: Renal Function Tests
Chronic Kidney Disease III: Interprofessional Care

